Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,740 | -227,006 | -166,307 | -111,123 | -47,411 |
| Depreciation Amortization | -959 | -120 | 225 | -54 | -149 |
| Income taxes - deferred | N/A | N/A | 265 | 265 | 265 |
| Accounts receivable | -2,897 | -10,765 | -7,481 | -2,353 | -1,351 |
| Accounts payable and accrued liabilities | 3,219 | -1,923 | 1,144 | -1,952 | 3,569 |
| Other Working Capital | -900 | -27,276 | -15,526 | 103 | -9,489 |
| Other Operating Activity | 6,510 | 37,017 | 25,849 | 16,864 | 3,340 |
| Operating Cash Flow | $-47,767 | $-230,073 | $-161,830 | $-98,251 | $-51,226 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -267 | -192 | -22 | -22 |
| Purchase Of Investment | -34,148 | -755,629 | -488,525 | -284,600 | -210,467 |
| Sale Of Investment | 150,417 | 275,601 | 184,757 | 123,880 | 57,504 |
| Investing Cash Flow | $116,269 | $-480,295 | $-303,959 | $-160,743 | $-152,985 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,432 | 664,177 | 660,542 | 282,047 | 277,567 |
| Financing Cash Flow | $1,432 | $664,177 | $660,542 | $282,047 | $277,567 |
| Beginning Cash Position | 61,446 | 107,637 | 107,637 | 107,637 | 107,637 |
| End Cash Position | 131,380 | 61,446 | 302,389 | 130,690 | 180,993 |
| Net Cash Flow | $69,934 | $-46,191 | $194,752 | $23,054 | $73,356 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,767 | -230,073 | -161,830 | -98,251 | -51,226 |
| Capital Expenditure | N/A | -267 | -192 | -22 | -22 |
| Free Cash Flow | -47,767 | -230,340 | -162,022 | -98,273 | -51,248 |